Potentiation and arming of lymphocyte mediated immunity by sera from melanoma patients.
D000372:Agglutination Tests; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D002460:Cell Line; D003601:Cytotoxicity Tests, Immunologic; D004137:Dinitrochlorobenzene / Q000276:immunology / Q000627:therapeutic use; D005260:Female; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D007951:Leukemia, Myeloid / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008545:Melanoma / Q000097:blood / Q000276:immunology* / Q000628:therapy; D009374:Neoplasms, Experimental / Q000276:immunology; D011247:Pregnancy; D012075:Remission, Spontaneous; D012878:Skin Neoplasms / Q000097:blood / Q000276:immunology* / Q000628:therapy; D013997:Time Factors
D000888:Antibodies, Anti-Idiotypic; D004137:Dinitrochlorobenzene; D006680:HLA Antigens